Multimodality imaging of bone marrow involvement in paediatric oncology

Identifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI and [18F]FDG-PET/CT as the most commonly used imagi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rutger A.J. Nievelstein, Lise Borgwardt, Thekla von Kalle, Annemieke S. Littooij, Lil-Sofie Ording Müller, Nelleke Tolboom
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:EJC Paediatric Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772610X2400045X
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Identifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI and [18F]FDG-PET/CT as the most commonly used imaging techniques. Interpretation of the paediatric bone marrow on imaging might be challenging because of age-related physiological changes in the bone marrow, as well as disease and therapy related effects. In this review, we discuss how the imaging techniques available may be employed to detect bone marrow involvement (BMI) in paediatric oncology. Furthermore, insights into physiological, disease and therapy related bone marrow changes in children that might influence bone marrow imaging interpretation will be provided.
ISSN:2772-610X